Probiotics, prebiotics, and allergy in children: what's new in the last year?

Michele Miraglia del Giudice1, Francesco Paolo Brunese

  • 1Dipartimento di Pediatria F. Fede, Seconda Università di Napoli, Naples, Italy. michele.miraglia@unina2.it

Insights

Probiotics show promising anti-inflammatory effects, potentially benefiting atopic dermatitis and influencing immune responses. Further research is needed to clarify strain-specific impacts on allergic airways and vaccine efficacy.

Area of Science:

  • Immunology
  • Microbiology
  • Gastroenterology

Background:

  • Emerging research highlights the immunomodulatory and anti-inflammatory capabilities of probiotics.
  • Clinical evidence suggests probiotics and prebiotics offer protective effects against atopic dermatitis, possibly via gastrointestinal mechanisms.

Purpose of the Study:

  • To review the current understanding of probiotic effects on immune-related conditions.
  • To explore the potential of probiotics in managing atopic dermatitis, allergic airway responses, and vaccine immunomodulation.

Main Methods:

  • Literature review of recent studies on probiotics and immune system interactions.
  • Analysis of clinical evidence regarding probiotic efficacy in atopic dermatitis and allergic diseases.
  • Evaluation of emerging data on probiotic influence on vaccine responses.

Main Results:

  • Probiotics possess confirmed immunomodulatory and anti-inflammatory properties.
  • Probiotic and prebiotic treatments show efficacy and protective effects in atopic dermatitis development.
  • Probiotic effects on allergic airway responses are strain-specific, requiring further mechanistic studies.
  • Probiotics may modulate vaccine responses, but clinical significance is yet to be determined.

Conclusions:

  • Probiotics demonstrate therapeutic potential in inflammatory and immune-mediated conditions.
  • Strain specificity is crucial for probiotic efficacy in allergic airway diseases.
  • Further investigation is warranted to establish the clinical relevance of probiotics in vaccine responses.

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Reactions02:06

Allergic Reactions

Overview
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms: